INFANRIX PENTA injection suspension GLAXO SMITH KLINE ORIGINAL MEDICINE
Chemical substance: DTP + HBV + IPV combination vaccine
ATC code: J07CAN1 • Antiinfectives for systemic use | Bacterial and viral vaccines, combined
Active substance
Results for the substance dtp+hbv+ipv combination vaccine
1 result
About this active substance
The combined DTP+HBV+IPV vaccine is used for active immunization against diphtheria, tetanus, pertussis (whooping cough), hepatitis B, and poliomyelitis. This vaccine contains components of Bordetella pertussis, diphtheria and tetanus toxoids, the hepatitis B surface antigen, and inactivated polioviruses.
The vaccine is administered intramuscularly, usually in multiple doses, according to recommended vaccination schedules for infants and young children. It is essential for preventing serious diseases such as poliomyelitis, chronic hepatitis B, and complications associated with diphtheria, tetanus, and whooping cough.
Common side effects include fever, irritability, drowsiness, and pain at the injection site. In rare cases, severe allergic reactions may occur.
The combined DTP+HBV+IPV vaccine is a crucial measure for protecting public health, helping to reduce the incidence of these infectious diseases and prevent severe complications associated with them.
The vaccine is administered intramuscularly, usually in multiple doses, according to recommended vaccination schedules for infants and young children. It is essential for preventing serious diseases such as poliomyelitis, chronic hepatitis B, and complications associated with diphtheria, tetanus, and whooping cough.
Common side effects include fever, irritability, drowsiness, and pain at the injection site. In rare cases, severe allergic reactions may occur.
The combined DTP+HBV+IPV vaccine is a crucial measure for protecting public health, helping to reduce the incidence of these infectious diseases and prevent severe complications associated with them.